Koo, S;
Neilson, LJ;
Von Wagner, C;
Rees, CJ;
(2017)
The NHS Bowel Cancer Screening Program: current perspectives on strategies for improvement.
Risk Management and Healthcare Policy
, 10
pp. 177-187.
10.2147/RMHP.S109116.
Preview |
Text
RMHP-109116-the-nhs-bowel-cancer-screening-programme--current-perspectiv_120117.pdf - Published Version Download (652kB) | Preview |
Abstract
Colorectal cancer (CRC) is the third most common cancer in the UK. The English National Health Service (NHS) Bowel Cancer Screening Program (BCSP) was introduced in 2006 to improve CRC mortality by earlier detection of CRC. It is now offered to patients aged 60-74 years and involves a home-based guaiac fecal occult blood test (gFOBt) biennially, and if positive, patients are offered a colonoscopy. This has been associated with a 15% reduction in mortality. In 2013, an additional arm to BCSP was introduced, Bowelscope. This offers patients aged 55 years a one-off flexible sigmoidoscopy, and if several adenomas are found, the patients are offered a completion colonoscopy. BCSP has been associated with a significant stage shift in CRC diagnosis; however, the uptake of bowel cancer screening remains lower than that for other screening programs. Further work is required to understand the reasons for nonparticipation of patients to ensure optimal uptake. A change of gFOBt kit to the fecal immunochemical tests (FIT) in the English BCSP may further increase patient participation. This, in addition to increased yield of neoplasia and cancers with the FIT kit, is likely to further improve CRC outcomes in the screened population.
Type: | Article |
---|---|
Title: | The NHS Bowel Cancer Screening Program: current perspectives on strategies for improvement |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.2147/RMHP.S109116 |
Publisher version: | https://doi.org/10.2147/RMHP.S109116 |
Language: | English |
Additional information: | This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (https://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms. |
Keywords: | colorectal cancer, flexible sigmoidoscopy screening, Bowelscope, CT colongraphy, fecal immunochemical tests, gFOBt screening, uptake, quality in colonoscopy |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Behavioural Science and Health |
URI: | https://discovery.ucl.ac.uk/id/eprint/10044702 |
Archive Staff Only
View Item |